Jpmorgan Chase & CO ALNYLAM PHARMACEUTICALS INC Transaction History
Jpmorgan Chase & CO
- $1.14 Trillion
- Q2 2024
Number of Shares
6,877,000
Previous 1,175,000
485.28%
Holding current value
$0
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions